Track glucose if relevant, A1C, weight, blood pressure, medicines, energy, thirst, urination, labs, nutrition context, and clinician goals.
Condition detail
Hypercalcemia
Hypercalcemia is an endocrine, hormone, bone-density, or nutrient-balance condition tracked with symptoms, labs, imaging when ordered, medicines or supplements, fractures or falls, and follow-up plans.
Connected records
Database matches for this condition
Palpitations
Palpitations is a heart, blood vessel, or circulation-related symptom that may be useful to track with pulse, blood pressure, swelling, exertion, and medication timing.
Cold intolerance
Cold intolerance is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.
Excessive sweating
Excessive sweating is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.
Fatigue
Fatigue is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.
General weakness
General weakness is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.
Heat intolerance
Heat intolerance is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.
Medication side effects
Medication side effects is a possible medicine, injection, allergy, or exposure-related symptom that is useful to record with timing, dose, route, and product details.
Unintentional weight changes
Unintentional weight changes is a metabolism, hormone, or blood-sugar-related symptom that may be tracked with food intake, glucose readings, medicines, hydration, and energy changes.
Bone pain
Bone pain is a muscle, joint, bone, or movement-related symptom that may be tracked with location, activity, injury, swelling, stiffness, and function.
Falls
Falls is a muscle, joint, bone, or movement-related symptom that may be tracked with location, activity, injury, swelling, stiffness, and function.
Calcitonin salmon
Used for: Calcitonin salmon injection, synthetic is a calcitonin, indicated for the following conditions: Treatment of symptomatic Paget's disease of bone when alternative treatments are not suitable ( 1.1 ) Treatment of hypercalcemia ( 1.2 ) Treatment of postmenopausal osteoporosis when alternative treatments are not suitable.
Cinacalcet
Used for: Cinacalcet is a positive modulator of the calcium sensing receptor indicated for: Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. ( 1.1 ) Limitations of Use : Cinacalcet tablets are not indicated for use in patients with CKD who are not on dialysis Hypercalcemia in adult patients with Parathyroid Carcinoma (PC).
Methylprednisolone
Used for: Methylprednisolone tablets are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer 2.
Prednisone
Used for: Prednisone tablets are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) Congenital adrenal hyperplasia Hypercalcemia associated with cancer Nonsuppurative thyroiditis 2.
Zoledronic acid
Used for: Zoledronic acid injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy. (1.1) Patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy.